docmed pharmaceutical and surgical private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 19 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 19 bids — NISHIKA ENTERPRISES appeared in 3 of them.
DOCMED PHARMACEUTICAL AND SURGICAL PRIVATE LIMITED
DOCMED PHARMACEUTICAL AND SURGICAL PRIVATE LIMITED
Financial Details
Registered Office
5465 ANAJ MANDI, AMBALA CANTTNA-AMBALA-Haryana-133001-India
Industry Classification
Trading
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
36
Contract Value
₹1.16 Cr
L1 Bids
1
Recent Win Rate
10.0%
Performance Analytics
DOCMED PHARMACEUTICAL AND SURGICAL PRIVATE LIMITED: Government Tender Analysis
Executive Summary
DOCMED PHARMACEUTICAL AND SURGICAL PRIVATE LIMITED is an active participant in the Indian government tender landscape, primarily focusing on pharmaceutical and surgical supplies. Analyzing their tender performance from April 2023 to March 2024 reveals key insights into their strengths, weaknesses, and strategic opportunities. The company has submitted 36 bids, achieving a win rate of 2.8%. Their qualification rate stands at 47.2% indicating room for improvement in meeting technical specifications. The company has secured contracts worth ₹1,16,37,753 (₹1.16 crore) demonstrating their capability to win valuable public sector projects. Despite securing notable contracts, TenderAI's financial health assessment rates DOCMED's financial health as 'Critical' with a score of 17.6/100, considering win rate, contract value, bid efficiency, growth, and consistency.
DOCMED's market positioning is defined by a concentrated focus on Haryana, Jammu & Kashmir, and Uttarakhand government tenders. They exhibit a specialization in tenders from the Department of Military Affairs and the Department of Defence, suggesting expertise in supplying to defense-related entities. While demonstrating a regional focus and departmental specialization, DOCMED faces competitive challenges reflected in their low win rate, suggesting a need to refine their bidding strategies to improve their market share in the Indian pharmaceutical sector and address the competitive landscape with companies like Niranjan Dass & Sons.
Financial Performance Analysis
Analyzing DOCMED's financial performance across different fiscal years reveals emerging trends and patterns:
| Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value (₹) |
|---|---|---|---|---|---|
| FY 2018-19 | 0 | 0 | 0.0% | 0.0% | 0 |